UA94033C2 - Use of pde3 inhibitor - Google Patents
Use of pde3 inhibitorInfo
- Publication number
- UA94033C2 UA94033C2 UAA200705721A UAA200705721A UA94033C2 UA 94033 C2 UA94033 C2 UA 94033C2 UA A200705721 A UAA200705721 A UA A200705721A UA A200705721 A UAA200705721 A UA A200705721A UA 94033 C2 UA94033 C2 UA 94033C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pde3 inhibitor
- pde3
- inhibitor
- mesotherapy
- cellulite
- Prior art date
Links
- 229940123263 Phosphodiesterase 3 inhibitor Drugs 0.000 title abstract 2
- 239000002570 phosphodiesterase III inhibitor Substances 0.000 title abstract 2
- 208000035484 Cellulite Diseases 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
- 238000000694 mesotherapy Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
There are disclosed pharmaceutical compositions for topical administration or for use in mesotherapy, containing a PDE3 inhibitor as an active ingredient, and their use in the treatment of cellulite.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20042371 ITMI20042371A1 (en) | 2004-12-14 | 2004-12-14 | TOPICAL PHARMACEUTICAL COMPOSITIONS FOR CELLULITE TREATMENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94033C2 true UA94033C2 (en) | 2011-04-11 |
Family
ID=38977008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200705721A UA94033C2 (en) | 2004-12-14 | 2005-12-06 | Use of pde3 inhibitor |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101076323B (en) |
| IT (1) | ITMI20042371A1 (en) |
| UA (1) | UA94033C2 (en) |
| ZA (1) | ZA200704859B (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802811B1 (en) * | 1999-12-24 | 2002-02-15 | Silab Sa | PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM BIGARADE PETALS, PARTICULARLY FOR THE TREATMENT OF CELLULITE, ACTIVE INGREDIENT OBTAINED, COSMETIC COMPOSITIONS AND SUITABLE TREATMENTS |
-
2004
- 2004-12-14 IT ITMI20042371 patent/ITMI20042371A1/en unknown
-
2005
- 2005-12-06 ZA ZA200704859A patent/ZA200704859B/en unknown
- 2005-12-06 UA UAA200705721A patent/UA94033C2/en unknown
- 2005-12-06 CN CN2005800427364A patent/CN101076323B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101076323B (en) | 2010-12-15 |
| ITMI20042371A1 (en) | 2005-03-14 |
| CN101076323A (en) | 2007-11-21 |
| ZA200704859B (en) | 2009-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| TW200605870A (en) | Topical methadone compositions and methods for using the same | |
| WO2004021968A3 (en) | Solution for ungual application | |
| WO2005041925A3 (en) | Compositions and dosage forms for enhanced absorption | |
| WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
| MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
| IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
| WO2008028965A3 (en) | Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof | |
| DE602005021770D1 (en) | INDOLE-1-YL-ACETIC DERIVATIVES | |
| TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
| PL1654253T3 (en) | Substituted 3-pyrrolidin-indole derivatives | |
| WO2009061431A3 (en) | Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor | |
| WO2007127333A3 (en) | Compositions for the treatment and prevention of eyelid swelling | |
| WO2008042480A3 (en) | Epoxide inhibitors of cysteine proteases | |
| PL1962815T3 (en) | Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers | |
| MXPA03010054A (en) | Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents. | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| WO2009088673A3 (en) | Pharmaceutical composition | |
| EP1503748A4 (en) | Drugs for mitigating taxane-induced neurotoxicity | |
| WO2003068157A3 (en) | Kinase inhibitors and methods of use thereof | |
| WO2003090688A3 (en) | Enhancement of human epidermal melanogenesis |